Sericin improves age-related copulatory impairment in rats through testosterone enhancement and PI3K/Akt/eNOS signaling modulation
Advanced Pharmaceutical Bulletin · 19.10.2026
DOI: 10.34172/apb.47643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 19.10.2026. Verfasst von Eisa Nakhostin Fathi und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
Impaired sexual behavior associated with aging remains a significant global health concern. Studies are investigating natural compounds to identify effective interventions for counteracting this condition. The present study examined the effectiveness of sericin (Ser) on age-related sexual impairment in aged rats.
Methods
A total of 10 young adult and 40 aged male Wistar rats were used. The aged animals were categorized into four groups and received NS or Ser at doses of 200, 250, and 300 mg/kg for 30 consecutive days. Copulatory behavior was assessed to evaluate sexual function. At the end of the behavioral assessment, serum testosterone levels, penile p-PI3K/PI3K, p-Akt/Akt, p-eNOS/eNOS, and p-NF-κB/NF-κB ratios, oxidative stress markers (TAC, MDA, GPx, and SOD), as well as cGMP, NO, IL-6 and TNF-α levels were measured. Notably, biochemical evaluations (n = 6/group) and Western blotting (n = 3/group) were conducted on representative subsets.
Results
The results demonstrated that Ser improved copulatory behavior in aged animals. The enhancement in sexual behavior was associated with increased PI3K/Akt/eNOS signaling and restoration of the NO/cGMP pathway, elevated testosterone levels, reduced lipid peroxidation, increased TAC and antioxidant enzyme activities, as well as diminished penile levels of IL-6 and TNF-α in aged rats.
Conclusion
These findings suggest that the ability of Ser to attenuate oxidative stress and inflammation may represent a promising approach for restoring testosterone levels and PI3K/Akt/eNOS signaling, thereby alleviating age-related sexual dysfunction. Nevertheless, further studies are required to clarify the mechanisms and evaluate therapeutic potential of Ser in the management of sexual dysfunction associated with aging.
Zitieren
APA
Fathi, E. N., Mirzaei, M., Mansouri, B., Athari, S. Z., Sadigh-Eteghad, S., Ebrahimi, F., Farajdokht, F., Mohammadi, A. B., & Mahmoudi, J. (2026). Sericin improves age-related copulatory impairment in rats through testosterone enhancement and PI3K/Akt/eNOS signaling modulation. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.47643
Vancouver
Fathi EN, Mirzaei M, Mansouri B, Athari SZ, Sadigh-Eteghad S, Ebrahimi F, et al. Sericin improves age-related copulatory impairment in rats through testosterone enhancement and PI3K/Akt/eNOS signaling modulation. Advanced Pharmaceutical Bulletin. 2026. doi:10.34172/apb.47643
BibTeX
@article{Fathi2026,
author = {Fathi, Eisa Nakhostin and Mirzaei, Mohammadreza and Mansouri, Behzad and Athari, Seyed Zanyar and Sadigh-Eteghad, Saeed and Ebrahimi, Fatemeh and Farajdokht, Fereshteh and Mohammadi, Ahad Banagozar and Mahmoudi, Javad},
title = {Sericin improves age-related copulatory impairment in rats through testosterone enhancement and PI3K/Akt/eNOS signaling modulation},
journal = {Advanced Pharmaceutical Bulletin},
year = {2026},
doi = {10.34172/apb.47643}
}
EUVIMED